Critics Rip Big Pharma Alternative To FDA Warning Label Plan
An industry-backed alternative to the U.S. Food and Drug Administration's plan to let generic-drug makers unilaterally update their warning labels is a ruse to expand immunity from product liability suits, consumer...To view the full article, register now.
Already a subscriber? Click here to view full article